Crystal's Coder Hub🧬 ICD-10-CM G20.C1 — Parkinsonism, Unspecified
Billable Code Confirmed — But Use With Caution
ICD-10-CM G20.C1 is a valid, billable 5-character alphanumeric ICD-10-CM code for FY2026. All five characters are present:
G20(category — Parkinson’s Disease) +.C(Parkinsonism, unspecified subcategory) +1(unspecified). No 7th character is required. Introduced effective October 1, 2023 (FY2024) as part of the G20 subcategory expansion replacing the retired singleG20code.G20.C1 is the last-resort code within the G20 family — it should be assigned ONLY when physician documentation genuinely does not permit a determination of whether Parkinsonism is idiopathic (G20.A/B subcodes) or secondary (G21.x codes). It is NOT a default for incomplete documentation, and it should NEVER be assigned when the physician has documented a specific form of Parkinsonism or when a CDI query could resolve the type.
Non-Billable Parent Code — Never Submit
STOP — Query Before Assigning G20.C1
G20.C1 should almost never be the final code assignment at a neurology encounter. Before assigning G20.C1, the coder must confirm ALL of the following:
- The physician has NOT documented “Parkinson’s disease,” “idiopathic Parkinson’s disease,” “primary Parkinsonism,” or “PD” (any of these → specific G20.A/B subcode)
- The physician has NOT documented a specific secondary cause — drug, vascular, postencephalitic, etc. (any of these → G21.x)
- The dyskinesia/fluctuation status CANNOT be determined from the record (if determinable → G20.A1/A2/B1/B2)
- A physician CDI query would NOT resolve the Parkinsonism type
If any of these conditions is NOT met → assign a specific code or issue a CDI query. G20.C1 is defensible ONLY when genuine diagnostic uncertainty persists after query and the physician documents that the type of Parkinsonism cannot be clinically established at the time of the encounter.
Code Classification
ICD-10-CM Diagnosis Code — Etiology code under the etiology/manifestation convention when dementia is also present. G20.C1 sequences FIRST when Parkinson’s disease dementia is coded — the F02.x dementia codes are mandatory manifestation codes that sequence second.
🔍 Code Description
ICD-10-CM G20.C1 classifies Parkinsonism of unspecified type — the clinical scenario in which a patient presents with parkinsonian features (bradykinesia, rigidity, rest tremor, postural instability) but the physician’s documentation does not permit a determination of whether the condition is idiopathic Parkinson’s disease (G20.A/B subcodes) or a secondary form of Parkinsonism (G21.x codes).
True diagnostic uncertainty between idiopathic and secondary Parkinsonism is not uncommon in clinical practice — particularly in:
- Emergency department and hospitalist encounters where the patient has an established neurology diagnosis but the admitting physician documents “Parkinsonism” without specifying type, and the neurologist has not yet been consulted
- New-onset Parkinsonism workup — early in the diagnostic process, before DaTscan, dopamine transporter imaging, or specialist evaluation has confirmed idiopathic vs. secondary etiology
- Atypical Parkinsonism presentations — where features suggest possible Parkinson’s-plus syndromes (PSP, MSA, CBD) rather than idiopathic PD, and the physician documents uncertainty about the specific type
- Patients without established neurology follow-up presenting to inpatient or urgent care settings
Despite its legitimate clinical use, G20.C1 is frequently overused — assigned by coders when the physician has documented “Parkinson’s disease” (which maps to the G20.A/B subcodes based on dyskinesia/fluctuation status) simply because the coder did not query for motor complication status. This is a coding error. “Parkinson’s disease” documented without motor complication specifiers maps to G20.A1 (no dyskinesia, no fluctuations by default) — NOT to G20.C1.
🌳 Code Tree / Hierarchy
G20-G26 Extrapyramidal and Movement Disorders
│
├── G20 — Parkinson's Disease ❌ Non-billable (retired as of FY2024)
│ │ [Use additional code for dementia]
│ │
│ ├── G20.A — PD Without Dyskinesia ❌ Non-billable header
│ │ ├── G20.A1 — Without dyskinesia, without fluctuations ✅ Billable
│ │ └── G20.A2 — Without dyskinesia, with fluctuations ✅ Billable
│ │
│ ├── G20.B — PD With Dyskinesia ❌ Non-billable header
│ │ ├── G20.B1 — With dyskinesia, without fluctuations ✅ Billable
│ │ └── G20.B2 — With dyskinesia, with fluctuations ✅ Billable
│ │
│ └── G20.C — Parkinsonism, Unspecified ❌ Non-billable header
│ └── G20.C1 — Parkinsonism, unspecified ◀ THIS CODE ✅ Billable
│ [ONLY when idiopathic vs. secondary genuinely undetermined;
│ last-resort code — query first]
│
├── G21 — Secondary Parkinsonism
│ ├── G21.11 — Neuroleptic induced Parkinsonism ✅ Billable
│ ├── G21.19 — Other drug induced secondary Parkinsonism ✅ Billable
│ ├── G21.3 — Postencephalitic Parkinsonism ✅ Billable
│ ├── G21.4 — Vascular Parkinsonism ✅ Billable
│ ├── G21.8 — Other secondary Parkinsonism ✅ Billable
│ └── G21.9 — Secondary Parkinsonism, unspecified ✅ Billable
│
└── G22 — Parkinsonism in diseases classified elsewhere ✅ Billable
The G20.C1 Decision Algorithm
Use this quick decision tree before assigning G20.C1:
- Did the physician document “Parkinson’s disease” or “idiopathic PD”? → YES → Do NOT use G20.C1 → query for dyskinesia/fluctuation status → assign G20.A1, G20.A2, G20.B1, or G20.B2
- Did the physician document a specific secondary cause (drug, vascular, postencephalitic)? → YES → Do NOT use G20.C1 → assign appropriate G21.x code
- Does the physician document “Parkinsonism” OR “Parkinson’s disease, type uncertain” with no etiology established? → YES → Can a CDI query resolve the type? → YES → Issue CDI query first → NO → Assign G20.C1 as last resort
✅ Includes
The following clinical terms and scenarios legitimately map to G20.C1 when idiopathic vs. secondary Parkinsonism genuinely cannot be determined:
- Parkinsonism, NOS — physician uses generic term “Parkinsonism” without specifying type and CDI query cannot resolve
- Parkinson’s disease, unspecified type — documentation does not permit idiopathic vs. secondary determination
- New-onset Parkinsonism, etiology under evaluation — early diagnostic workup phase; no etiology yet confirmed
- Parkinsonism with atypical features — physician documents uncertainty about specific Parkinsonism type (e.g., possible PD vs. MSA vs. PSP — atypical Parkinsonism NOS when no specific Parkinson’s-plus syndrome is documented separately)
- Parkinsonism documented by non-neurologist without etiology specification
"Parkinson's Disease" Documented by Physician → Do NOT Use G20.C1
If the physician writes “Parkinson’s disease” anywhere in the record — assessment, problem list, medication indication, history — this constitutes documentation of idiopathic Parkinson’s disease and maps to the G20.A/B subcategory, NOT G20.C1. The coder should query for dyskinesia/fluctuation status to select the specific subcode. G20.C1 applies only when the word “disease” is absent and the etiology is genuinely ambiguous — e.g., “Parkinsonism” or “parkinsonian features” without further specification.
❌ Excludes
Excludes 1 — When These Are Identified, Do NOT Use G20.C1
| Code | Description | Note |
|---|---|---|
| G21.11 | Neuroleptic induced Parkinsonism | When drug etiology (antipsychotic, metoclopramide, prochlorperazine) is the documented cause → G21.11 or G21.19, never G20.C1 |
| G21.19 | Other drug induced secondary Parkinsonism | Same — any documented drug etiology → G21.x |
| G21.3 | Postencephalitic Parkinsonism | Documented encephalitis history → G21.3 |
| G21.4 | Vascular Parkinsonism | Documented vascular etiology (white matter disease, lacunar infarcts) → G21.4 |
| G21.8 | Other secondary Parkinsonism | Any other documented secondary cause → G21.8 |
| G21.9 | Secondary Parkinsonism, unspecified | When secondary Parkinsonism is known but specific cause undetermined → G21.9; NOT G20.C1 |
G20.C1 vs. G21.9 — A Critical Distinction
Both G20.C1 (Parkinsonism, unspecified) and G21.9 (Secondary Parkinsonism, unspecified) are “unspecified” codes — but they represent clinically distinct uncertainty:
- G20.C1 = Uncertainty about whether Parkinsonism is idiopathic OR secondary — the broad category is unresolved
- G21.9 = Parkinsonism is known to be secondary (not idiopathic), but the specific secondary cause has not been identified
These codes are NOT interchangeable. If a physician documents “secondary Parkinsonism, cause under investigation” → G21.9, not G20.C1. If a physician documents “Parkinsonism — unclear if primary or secondary” → G20.C1 is appropriate after a query attempt.
📋 Clinical Overview
When Is G20.C1 Genuinely Appropriate?
True diagnostic uncertainty between idiopathic and secondary Parkinsonism is most common in four clinical scenarios:
| Scenario | Clinical Context | Appropriate Action |
|---|---|---|
| New-onset Parkinsonism, neurology not yet seen | ED or hospitalist encounter; patient with new tremor, bradykinesia, rigidity; neurology not yet consulted; no prior PD diagnosis | Assign G20.C1 as principal if the condition drives the encounter; add neurology consult query in CDI workflow |
| Early diagnostic workup — etiology not yet confirmed | Neurology has evaluated but DaTscan/dopamine transporter imaging pending; physician explicitly documents “Parkinsonism, etiology TBD” | G20.C1 appropriate for this encounter; follow up record after workup completion |
| Atypical Parkinsonism features | Physician documents “atypical Parkinsonism” or “possible Parkinson’s-plus syndrome” without specifying PSP, MSA, or CBD separately | G20.C1 may be appropriate if no specific Parkinson’s-plus syndrome is named; if PSP or MSA is named → G23.x codes |
| Non-neurologist documentation | PCP or hospitalist documents “Parkinsonism” without type specification; neurologist not yet involved in the record | Issue CDI query for neurologist confirmation; if not resolvable → G20.C1 |
Atypical Parkinsonism — When G20.C1 Is NOT the Right Code
When the physician documents a specific atypical Parkinsonian syndrome, the G23.x subcategory — Other Degenerative Diseases of Basal Ganglia — applies instead of G20.C1:
| Condition | Correct Code |
|---|---|
| Progressive supranuclear palsy (PSP) | G23.1 — Progressive supranuclear palsy |
| Multiple system atrophy (MSA) | G23.3 — Striatonigral degeneration / or G90.3 for MSA |
| Corticobasal degeneration (CBD) | G23.8 — Other specified degenerative diseases of basal ganglia |
| Dementia with Lewy bodies (DLB) | G31.83 — Dementia with Lewy bodies |
Do Not Confuse "Atypical Parkinsonism" With "Parkinsonism, Unspecified"
When a physician documents “progressive supranuclear palsy” or “multiple system atrophy,” these are NOT coded to G20.C1 — they have specific codes in the G23.x range. G20.C1 applies only when NO specific Parkinson’s-plus syndrome is named and the idiopathic vs. secondary distinction is genuinely unresolved. If the physician documents “atypical Parkinsonism — possible PSP vs. PD,” a CDI query is warranted; G20.C1 may be appropriate as a holding code pending diagnostic resolution.
Documentation Requirements
For defensible assignment of G20.C1, the record should reflect:
- Parkinsonian features documented — bradykinesia, rigidity, rest tremor, postural instability — clinical basis for the Parkinsonism diagnosis
- No specific etiology identified — no documentation of “Parkinson’s disease,” “idiopathic PD,” drug cause, vascular cause, postencephalitic cause, or specific Parkinson’s-plus syndrome
- Genuine diagnostic uncertainty — the physician’s documentation reflects that the type of Parkinsonism is not yet established (not simply omitted due to incomplete documentation)
- CDI query attempted or not possible — document the query attempt in the coding workflow; if the physician confirms “Parkinsonism, type undetermined at this time” → G20.C1 is defensible
- Dementia status — if dementia is present, document severity and behavioral disturbance type for the mandatory F02.x code pair
💰 HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (100% Implementation FY2026) |
| HCC Assignment | ✅ Mapped — HCC 155 |
| HCC Category Name | Parkinson’s Disease and Huntington’s Disease |
| RAF Coefficient (Community Non-Dual Aged) | ~0.372 |
| G20 Subcode Differentiation | G20.C1 maps to same HCC 155 as G20.A1/A2/B1/B2 — unspecified subcode does not differentiate HCC tier |
| Risk Adjustment Audit Flag | ✅ G20.C1 is an unspecified code — risk adjustment auditors may flag for clinical refinement query; specificity upgrade to G20.A1/A2/B1/B2 is preferred when documentation supports it |
G20.C1 maps to CMS-HCC v28 HCC 155 for the same RAF as the specific G20 subcodes — meaning there is no RAF penalty for using G20.C1 vs. a specific subcode. However, risk adjustment audit processes (RADV audits for MA, retrospective reviews for fee-for-service) may challenge G20.C1 if the underlying documentation actually supports a more specific code. Coding specificity compliance — not RAF optimization — is the primary driver for upgrading G20.C1 to a specific subcode when documentation permits.
G20.C1 in Risk Adjustment — Audit Exposure
Under RADV audit, a submitted G20.C1 code will be validated against the medical record. If the record contains documentation of “Parkinson’s disease” (even on a problem list or medication indication) that was not queried for motor complication status, the auditor may reject G20.C1 as insufficiently specific and not map it to HCC 155 — creating an HCC deletion that affects the risk score. The audit-safest approach: never assign G20.C1 when the documentation contains “Parkinson’s disease” — query for the specific subcode instead.
🏥 MS-DRG Assignment
MDC 01 — Diseases and Disorders of the Nervous System
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 056 | Degenerative Nervous System Disorders with MCC | ~2.23 |
| DRG 057 | Degenerative Nervous System Disorders without MCC | ~1.30 |
*Approximate. Verify against IPPS FY2026 Final Rule tables. Only two DRGs exist for this pair — no DRG 058.
G20.C1 as Principal — Inpatient CDI Opportunity
An inpatient encounter where G20.C1 appears as the principal diagnosis — rather than a specific G20.A/B subcode — represents a near-universal CDI opportunity. At a minimum, the CDI/coding team should query whether the patient has an established Parkinson’s disease diagnosis (problem list, medication indication, prior neurology records) that would support upgrading to G20.A1/A2/B1/B2 before discharge. A specific subcode does not yield higher DRG reimbursement — DRG grouping is the same — but it provides better clinical complexity documentation and stronger audit defensibility.
🔗 Related ICD-10-CM Codes
G20 Full Motor Complication Matrix
| Code | Description | When to Use |
|---|---|---|
| G20.A1 | Without dyskinesia, without mention of fluctuations | Idiopathic PD confirmed; no motor complications; or “Parkinson’s disease” documented without specification (default specific subcode when no complications present) |
| G20.A2 | Without dyskinesia, with fluctuations | Idiopathic PD confirmed; wearing-off or OFF episodes documented; no dyskinesia |
| G20.B1 | With dyskinesia, without mention of fluctuations | Idiopathic PD confirmed; dyskinesia documented; no wearing-off |
| G20.B2 | With dyskinesia, with fluctuations | Idiopathic PD confirmed; both dyskinesia AND wearing-off documented |
| G20.C1 | Parkinsonism, unspecified ← This Code | Idiopathic vs. secondary genuinely undetermined; last resort only |
Secondary Parkinsonism — Excludes1 from G20; Use These When Etiology Is Known
| Code | Description | Use When |
|---|---|---|
| G21.11 | Neuroleptic induced Parkinsonism | Dopamine-blocking drug (antipsychotic, metoclopramide) is documented cause |
| G21.19 | Other drug induced secondary Parkinsonism | Other drug-induced, non-neuroleptic etiology |
| G21.3 | Postencephalitic Parkinsonism | Encephalitis history documented as cause |
| G21.4 | Vascular Parkinsonism | Vascular etiology (white matter disease, lacunar infarcts) documented |
| G21.8 | Other secondary Parkinsonism | Other identified secondary cause |
| G21.9 | Secondary Parkinsonism, unspecified | Secondary Parkinsonism confirmed but specific cause not identified |
Atypical Parkinsonism — When Specific Syndrome Is Named
| Code | Description |
|---|---|
| G23.1 | Progressive supranuclear palsy (PSP) |
| G23.3 | Striatonigral degeneration (MSA-P) |
| G23.8 | Other specified degenerative diseases of basal ganglia (CBD) |
| G31.83 | Dementia with Lewy bodies (DLB) |
| G90.3 | Multi-system degeneration of the autonomic nervous system (MSA-A/MSA-C) |
Mandatory Associated Codes — Dementia (Use Additional Code per Tabular Instruction)
| Code | Description | HCC v28 |
|---|---|---|
| F02.80 | Dementia in other diseases, unspecified severity, without disturbance | HCC 127 |
| F02.A0 | Dementia in other diseases, mild, without disturbance | HCC 127 |
| F02.B0 | Dementia in other diseases, moderate, without disturbance | HCC 126 |
| F02.C0 | Dementia in other diseases, severe, without disturbance | HCC 125 |
| F02.B1 | Dementia in other diseases, moderate, with behavioral disturbance | HCC 126 |
| F02.C1 | Dementia in other diseases, severe, with behavioral disturbance | HCC 125 |
🛠️ Commonly Associated CPT Codes (Neurology)
Outpatient and Physician Setting Context
At the G20.C1 stage, the encounter is often diagnostic — establishing etiology — rather than advanced therapy management. CPT codes reflect evaluation, diagnostic workup, and initial management.
| CPT Code | Description | Clinical Application |
|---|---|---|
| 99204 | Office or other outpatient visit, new patient, moderate MDC | New patient evaluation for new-onset Parkinsonism — history, neurological examination, differential diagnosis formulation |
| 99205 | Office or other outpatient visit, new patient, high MDC | Complex new Parkinsonism evaluation — atypical features, multiple comorbidities, advanced diagnostic planning (DaTscan, neuroimaging, neuropsychological testing) |
| 99214 | Office or other outpatient visit, established patient, moderate MDC | Follow-up during Parkinsonism workup — test result review, medication initiation/adjustment, differential diagnosis refinement |
| 99215 | Office or other outpatient visit, established patient, high MDC | Complex follow-up — emerging atypical features, diagnostic uncertainty discussion, multiple management decisions |
| 96132 | Neuropsychological testing evaluation; first hour | Neuropsychological battery — part of Parkinsonism diagnostic workup; cognitive profile helps differentiate idiopathic PD (relatively preserved cognition early) from PSP, DLB, CBD (earlier cognitive/behavioral involvement) |
| 96133 | +Neuropsychological testing evaluation; each additional hour | Add-on; never alone |
| 96116 | Neurobehavioral status exam; first hour | Office-based cognitive screen — MoCA, MMSE as part of Parkinsonism initial evaluation; helps establish cognitive baseline |
| 95923 | Testing of autonomic nervous system function | Autonomic function testing — relevant in Parkinsonism workup to differentiate MSA (prominent autonomic failure) from idiopathic PD |
| 70553 | MRI brain with and without contrast | Brain MRI — key diagnostic workup for new Parkinsonism; assesses for structural causes, vascular Parkinsonism (white matter disease), PSP (hummingbird sign), MSA (hot cross bun sign) |
| 78607 | Brain imaging, tomographic (SPECT) | DaTscan (dopamine transporter SPECT imaging) — distinguishes dopaminergic (idiopathic PD, PSP, MSA) from non-dopaminergic Parkinsonism (vascular, drug-induced, essential tremor misdiagnosis); the primary imaging test for Parkinsonism etiology clarification |
NCCI Bundling Considerations
NCCI PTP Edits — Verify Before Billing
- 96132 (neuropsychological testing) and 96116 (neurobehavioral status exam) on the same DOS: verify NCCI PTP edit status; both may be appropriate in a comprehensive Parkinsonism workup but documentation must support each as independently necessary.
- 99204/99205 (new patient E/M) and 96116 same DOS: verify bundling; modifier -25 required on E/M if 96116 is also billed.
- 78607 (DaTscan) — professional component (-26) applies if the neurologist interprets the scan; technical component (-TC) applies if the facility performs the scan; global billing if same physician performs both.
- 95923 (autonomic testing) — ensure documentation of medical necessity and that testing is performed by or under supervision of the billing physician.
🔬 ICD-10-PCS Crosswalk (Inpatient Procedures)
At the G20.C1 stage, inpatient procedures are primarily diagnostic rather than therapeutic device implantation. Advanced therapy PCS codes (DBS, LCIG/J-tube) are deferred until idiopathic PD is confirmed and etiology is clarified.
| PCS Section | Body System | Root Operation | Clinical Application |
|---|---|---|---|
| B (Imaging) | 3 (Central Nervous System) | 3 (MRI) | B030YZZ — MRI brain without contrast; B031YZZ — MRI brain with contrast; new Parkinsonism workup |
| C (Nuclear Medicine) | 3 (Central Nervous System) | 1 (Planar Nuclear Medicine Imaging) | DaTscan SPECT — dopamine transporter imaging; primary inpatient workup study when Parkinsonism etiology is unresolved |
| G (Mental Health) | Z (None) | 3 (Psychological Tests) | GZ3ZZZZ — Neuropsychological testing; Parkinsonism diagnostic workup including cognitive profiling for differential diagnosis |
| 4 (Measurement and Monitoring) | A (Physiological Systems) | 0 (Measurement) | 4A0FXMZ — Autonomic nervous system measurement; relevant when MSA vs. idiopathic PD is under consideration |
💊 Coding Scenarios and Examples
Scenario 1 — New-Onset Parkinsonism, Etiology Undetermined, ED Presentation (Inpatient)
Clinical Vignette: A 70-year-old female with no prior neurological diagnosis is admitted from the ED with new-onset bradykinesia, cogwheel rigidity, and resting tremor. No prior Parkinson’s disease diagnosis. She takes metoclopramide for GERD. Admitting hospitalist documents: “New-onset Parkinsonism — etiology undetermined; metoclopramide-induced vs. idiopathic PD under evaluation. Neurology consult requested.”
Principal Diagnosis:
- G20.C1 — Parkinsonism, unspecified (etiology genuinely undetermined at time of coding; CDI query to neurology pending)
G20.C1 Is Appropriate Here — But Should Be Revisited After Neurology Consult
This is a legitimate G20.C1 scenario — the admitting physician has explicitly documented that the etiology is undetermined. However, once neurology documents their assessment (idiopathic PD vs. drug-induced from metoclopramide), the code should be updated: idiopathic PD → G20.A1/A2/B1/B2; drug-induced → G21.19 (metoclopramide-induced Parkinsonism). The CDI team should track the neurology consult note before final code assignment at discharge.
Scenario 2 — “Parkinsonism” Documented by PCP, No Etiology Specified (Outpatient)
Clinical Vignette: A 67-year-old male is seen by his PCP for tremor and slow movement. PCP documents: “Parkinsonism — referring to neurology for evaluation.” No prior PD diagnosis. No medication known to cause Parkinsonism.
CPT Codes:
- 99213 — Office visit, established patient, low MDC (tremor/Parkinsonism evaluation, referral)
ICD-10-CM:
- G20.C1 — Parkinsonism, unspecified (PCP documentation without etiology specification; neurology referral pending; no basis for specific G20.A/B or G21.x)
Follow the Encounter Through — G20.C1 Is a Bridge Code
When G20.C1 is assigned in an outpatient setting during the initial workup phase, the code should be revised at the neurology encounter once the specific type is established. G20.C1 is best understood as a bridge code — appropriate during the diagnostic evaluation window, not as a permanent code for a patient with established Parkinson’s disease.
Scenario 3 — “Parkinson’s Disease” on Problem List Without Motor Complication Spec — Do NOT Use G20.C1
Clinical Vignette: A 72-year-old male is seen in neurology follow-up. Problem list reads: “Parkinson’s disease.” No documentation of dyskinesia or wearing-off status in today’s note. Coder considers assigning G20.C1 because motor complication status is unstated.
CORRECT Approach:
- Do NOT assign G20.C1 — “Parkinson’s disease” documented = idiopathic PD confirmed → G20.A or G20.B subcategory
- Coder should issue a CDI query: “Does the patient experience wearing-off or OFF episodes? Is dyskinesia present?”
- G20.C1 is never appropriate when the physician has documented “Parkinson’s disease”
Scenario 4 — Parkinsonism Workup With DaTscan (Outpatient)
Clinical Vignette: A 64-year-old female is referred to neurology for new Parkinsonism. Neurologist documents: “Parkinsonism, etiology uncertain — atypical features present. DaTscan ordered to assess dopaminergic integrity.” DaTscan is ordered same DOS.
CPT Codes:
- 99205 — New patient office visit, high MDC (new diagnosis, complex workup planning, atypical features); append modifier -25 if DaTscan interpreted same DOS
- 78607 — Brain imaging, tomographic (SPECT) — DaTscan (when billed by interpreting neurologist: append modifier -26 — professional component only)
ICD-10-CM:
- G20.C1 — Parkinsonism, unspecified (physician explicitly documents uncertainty; diagnostic workup in progress)
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | Never assign G20.C1 when “Parkinson’s disease” is documented — “Parkinson’s disease” = idiopathic PD = G20.A or G20.B subcategory; query for motor complication status and assign specific subcode |
| ❌ | Never use G20.C1 as the default for incomplete documentation — G20.C1 is for genuine diagnostic uncertainty about Parkinsonism TYPE, not for documentation that omits motor complication status |
| ❌ | Do not confuse G20.C1 with G21.9 — G20.C1 = uncertainty whether idiopathic OR secondary; G21.9 = known secondary Parkinsonism with unidentified specific cause; they are different uncertainty types |
| ❌ | Do not use G20.C1 when a specific Parkinson’s-plus syndrome is named — PSP → G23.1; MSA → G23.3 or G90.3; CBD → G23.8; DLB → G31.83 |
| ❌ | Do not submit the retired bare G20 or non-billable G20.C — only G20.C1 is billable in the G20.C subcategory |
| ❌ | Do not sequence F02.x as principal — Parkinson’s dementia codes are mandatory manifestation codes; G20.C1 sequences first |
| ✅ | Always query before assigning G20.C1 — a CDI query for Parkinsonism type should be the first action; only assign G20.C1 when the query cannot or does not resolve the type |
| ✅ | Treat G20.C1 as a bridge code — revisit and update to a specific code at every opportunity as the workup progresses |
| ✅ | When drug-induced Parkinsonism is possible — query for medication review (antipsychotics, metoclopramide, prochlorperazine, valproate, calcium channel blockers) before assigning G20.C1; if causative drug identified → G21.11 or G21.19 |
| ✅ | DaTscan result resolves G20.C1 — a positive DaTscan (reduced dopamine transporter uptake) confirms dopaminergic Parkinsonism (idiopathic PD, PSP, MSA) → upgrade to specific G20.A/B or G23.x; a negative DaTscan suggests non-dopaminergic cause → G21.x or other |
| ✅ | Code comorbid dementia regardless of Parkinsonism subcode — the F02.x “Use additional code” instruction applies to G20.C1 just as it does to all G20 subcodes |
| ✅ | Risk adjustment audit risk — G20.C1 is more vulnerable than specific G20 subcodes under RADV audit if the record contains undiscovered “Parkinson’s disease” documentation; query and specificity upgrade is the audit-safest approach |
📚 Sources
-
CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Tabular List — G20.C1; G20 category structure; Use additional code instructions; Etiology/Manifestation Convention (Section I.B.13); Code to the Highest Level of Specificity (Section I.A.3).
-
AHA Coding Clinic. Q1 2024 — Parkinson’s Disease: Dyskinesia vs. Tremor. Guidance on G20.A/B/C subcode selection; documentation specificity requirements.
-
AHA Coding Clinic (via medlearn.com). Coding Update: An Index Change for Parkinson’s Disease. March 2026. Alphabetic Index cross-references for G20 subcategory selection.
-
AHA Coding Clinic. Learn to Code: Parkinson’s Disease. April 2024 (codingclinicadvisor.com). G20.C — Parkinsonism, unspecified; use-with-caution guidance.
-
AAPC. ICD-10 Code for Parkinsonism, Unspecified (G20.C1). Tabular structure and billable subcode confirmation.
-
UASI Solutions. Parkinson’s Disease Tremor vs. Dyskinesia Coding. April 2025. G20 subcode selection algorithm.
-
CMS. 2026 Medicare Advantage CMS-HCC Model v28 — Final Risk Adjustment Coefficients. HCC 155 (Parkinson’s Disease and Huntington’s Disease).
-
CMS. IPPS Final Rule FY2026 — MS-DRG Definitions Manual v43. MDC 01; DRG 056/057.
-
CMS. RADV Audit Protocol and Medical Record Review Guidelines. Coding specificity requirements for HCC validation; unspecified code audit risk.
-
AMA. CPT Professional Edition 2026. Neurology; DaTscan; neuropsychological testing; E/M guidelines.
-
CMS. NCCI Policy Manual for Medicare Services, current version.